ADMA Biologics Inc Capital Reinvestment Ratio
ADMA Biologics Inc capital reinvestment ratio. ADMA Biologics Inc (ADMA) has a Capital Reinvestment Ratio of 0.08x as of June 2026, meaning it reinvests 0% of its operating cash flow ($29.54 Million) in capital expenditures ($2.26 Million). See free cash flow generation of ADMA Biologics Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ADMA Biologics Inc (2023–2025)
Capital reinvestment ratio of ADMA Biologics Inc from 2023 to 2025. This chart tracks ADMA Biologics Inc's Capital Reinvestment Ratio across 3 annual periods. See financial agility of ADMA Biologics Inc to measure the company's free cash flow as a share of total liabilities.
ADMA Biologics Inc Capital Reinvestment Ratio by Year (2023–2025)
ADMA Biologics Inc capital reinvestment ratio by year from 2023 to 2025. For the full cash flow conversion analysis, see ADMA Biologics Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | $50.40 Million | $22.57 Million | ▲ +519.9% |
| 2024 | 0.07x | $118.67 Million | $8.57 Million | ▼ -87.2% |
| 2023 | 0.57x | $8.80 Million | $4.98 Million | — |